Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1479-5876

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711 ; volume:16 ; number:1 ; day:9 ; month:5 ; year:2018 ; pages:1-14 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (9.5.2018), 1-14, 12.2018

Creator: Lindström, Erik

Contributor: Rizoska, Biljana
Henderson, Ian
Terelius, Ylva
Jerling, Markus
Edenius, Charlotte
Grabowska, Urszula
SpringerLink (Online service)

DOI: 10.1186/s12967-018-1497-4

URN: urn:nbn:de:101:1-2018072917314656592213

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lindström, Erik
Rizoska, Biljana
Henderson, Ian
Terelius, Ylva
Jerling, Markus
Edenius, Charlotte
Grabowska, Urszula
SpringerLink (Online service)

Other Objects (12)

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

Virtual Control Groups in Nonclinical Studies

Hochschulschrift

Complementaktivierung durch Cathepsin D

Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist

Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate

Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors

Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia

Voice-selective prediction alterations in nonclinical voice hearers

Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

Virtual Control Groups in Nonclinical Studies

Hochschulschrift

Complementaktivierung durch Cathepsin D

Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist

Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate

Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors

Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia

Voice-selective prediction alterations in nonclinical voice hearers

Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

Virtual Control Groups in Nonclinical Studies

Hochschulschrift

Complementaktivierung durch Cathepsin D

Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist

Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate

Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors

Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia

Voice-selective prediction alterations in nonclinical voice hearers

Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

Virtual Control Groups in Nonclinical Studies

Complementaktivierung durch Cathepsin D

Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist

Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate

Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors

Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia

Voice-selective prediction alterations in nonclinical voice hearers

Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

Virtual Control Groups in Nonclinical Studies

Complementaktivierung durch Cathepsin D

Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist

Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate

Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors

Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia

Voice-selective prediction alterations in nonclinical voice hearers

Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

Virtual Control Groups in Nonclinical Studies

Complementaktivierung durch Cathepsin D

Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist

Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate

Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors

Expression and significance of cathepsin C and cathepsin D during pregnancy and Preeclampsia

Voice-selective prediction alterations in nonclinical voice hearers

Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist

Related objects

Reset password